However, the American guideline, despite its apparent patient-centered approach, in which the patient would have participated in decision-making, strongly recommends statin therapy for people with cardiovascular risk ≥7.5% race- and sex-specific pooled cohort equations.
Sin embargo, la guía estadounidense, pese a su pretendido enfoque centrado en el paciente, al que se haría partícipe de las decisiones, hace una recomendación firme de tratamiento con estatinas para personas con riesgo cardiovascular ≥7,5% race and sex-specific pooled cohort equations.